Chitosan as a novel nasal delivery system for vaccines.
By L. Illum, I. Jabbal‐Gill, M. Hinchcliffe, A. Fisher, S. Davis. Advanced Drug Delivery Reviews, 2001
752 citations recorded by the source corpus.
Subfields: Molecular Biology, Pharmaceutical Science, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/a0f7954678114b7d91bd6ec0562fad1daef41034
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Pharmaceutical Science
Citations in the corpus
- Chitosan—A versatile semi-synthetic polymer in biomedical applications (2011, neutral): “been studied [325–344].”
- Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems (2018, background): “Chitosan endocytosis was saturable, i.e., cellular association increased linearly with concentration (31.25–1000 µ g/mL) and reached a steady state at some point.”
- Mucoadhesive polymeric platforms for controlled drug delivery. (2009, background): “Such polymeric delivery platforms may be used either alone or as synergistic combination systems [105–108].”
- Chitosan microspheres as a potential carrier for drugs. (2004, background): “Properties such as biodegradability, low toxicity and good biocompatibility make it suitable for use in biomedical and pharmaceutical formulations (Chandy and Sharma, 1990; Illum et al., 2001), e.”